In this issue of HEALTHbeat:
  • 12 things you should know about pain relievers
  • Can glucosamine and chondroitin sulfate help osteoarthritis of the knee?

Help us be sure this email newsletter isn’t filtered as spam. Add HEALTHbeat@hms.harvard.edu to your address book to ‘whitelist’ us with your filter, helping future issues get to your inbox.
 
Read this issue online Tell your friends | View the HEALTHbeat archives | RSS
Harvard Health Publications -- Harvard Medical School HEALTHbeat
April 10, 2007

Dear HEALTHbeat subscriber,

Take a walk down the pain relief aisle at your local drugstore and I bet you’ll be as overwhelmed by the choices as I am.  Choosing the nonprescription pain reliever that’s best for what ails you can be, well, a pain. In this issue of HEALTHbeat you’ll find 12 important facts to help you understand the array of choices and choose the product that’s right for you. Also in this issue, Dr. Donald T. Reilly discusses the long-term use of cortisone shots for arthritis pain.

Wishing you good health,


Nancy Ferrari
Managing Editor
Harvard Health Publications
HEALTHbeat@hms.harvard.edu

In This Issue
1 12 things you should know about pain relievers
[READ]
2 Notable from Harvard Medical School:
* Low-Back Pain: Healing
   your aching back
* Arthritis: Keeping your
   joints healthy
[READ]
3 Glucosamine and chondroitin sulfate for osteoarthritis of the knee
[READ]

Harvard Health Publications and the Harvard Business School will present “Business Preparedness for Pandemic,” a four-day summit for business and government leaders to be held at Harvard Medical School May 14–17, 2007. For program details and registration information, please go to www.preparedforpandemic.com.

From Harvard Medical School
Knees and Hips: A troubleshooting guide to knee and hip pain

In Knees and Hips: A troubleshooting guide to knee and hip pain, you’ll find expert solutions to painful knee and hip problems. From exercise and physical therapy to surgical options such as arthroscopy and joint replacement, you’ll discover the best prevention and treatment options available today. If you suffer from these painful joints, this report can help you find relief.
[READ MORE]
 
FREE SHIPPING
Invite someone to sign up for HEALTHbeat and you both will receive a FREE gift.
Click here to start.
 

1\ 12 things you should know about pain relievers

A dozen take-home messages about the pills that take the hurt away.

Remember when it was so simple? Take two aspirin, call the doctor in the morning. Now we’ve got a staggering number of pain relievers to choose from. Picking the right one is enough to give you a headache! And whatever you might think about the Vioxx debacle, it certainly made us aware that these medications — even the ones sold over the counter — are serious drugs, capable of doing great harm as well as rescuing us from some awful pain. So here are a few pointers to help you navigate the pain reliever aisle.

Pain relievers at a glance

 

Brand names

Comment

acetaminophen

Tylenol

Not an NSAID; doesn’t cause stomach problems like NSAIDs; common ingredient in headache and cold medicines; large amounts cause liver damage.

NSAIDs

Aspirin

Many brand names

Technically an NSAID, but its anticlotting properties make it unique; alternatives and bleeding risk at high doses means it’s not used as much as a pain reliever now.

diclofenac

Cataflam, Voltaren

Used in drops to reduce swelling after eye surgery. As oral drug, may have highest risk of cardiovascular side effects of older NSAIDs.

ibuprofen

Advil, Motrin, Nuprin

Favored because it acts quickly without staying in the body too long, so per dose it has a lower risk of causing stomach and kidney problems.

indomethacin

Indocin

Available as a suppository — valuable when you have nausea as well as pain; headache and dizziness side effects have made it less popular.

naproxen

Aleve, Naprosyn

Longer acting than ibuprofen; may have fewer cardiovascular side effects than other NSAIDs.

piroxicam

Feldene

Very long acting (24 hours), which doctors concerned with NSAID side effects see as a major drawback.

sulindac

Clinoril

Some findings suggest it’s easier on the kidneys, but others raise doubts.

COX-2 inhibitors

celecoxib

Celebrex

Low doses (200 mg per day or less) may pose less cardiovascular risk than other COX-2 inhibitors.

meloxicam

Mobic

Replaced celecoxib and rofecoxib in some countries (for example, Australia); pharmacologically in a gray area between traditional NSAIDs and COX-2 inhibitors; less risky than Vioxx; relatively few studies of its risks.

rofecoxib

Vioxx

Pulled off the market in 2004. Associated with kidney and heart risks.

1. Tylenol can cause liver damage. The active ingredient in Tylenol is acetaminophen. Acetaminophen overdoses, half of them unintentional, are now the leading cause of acute liver failure in the United States. Four grams per day (about 12 regular-strength Tylenol tablets) is considered the safe upper limit, but that might be too much for some. Large doses are the main risk, but there are reports of people developing liver problems after taking small to moderate amounts of acetaminophen for long periods of time.

Warning: People who drink alcohol regularly or have a less than healthy liver are more vulnerable to acetaminophen’s toxic effects, so the safety threshold for them is lower. Exactly how much lower is difficult to say, but some experts say that to be on the safe side, heavy drinkers shouldn’t take more than 2 grams daily.

Acetaminophen is an ingredient in many over-the-counter cold and headache medications; for example, Extra Strength Excedrin contains 250 mg. Prescription pain relievers like Percocet and Vicodin also contain acetaminophen. Some people may be taking more of the drug than they realize because of these “hidden sources.”

The danger here needs to be kept in perspective. Millions of Americans take acetaminophen every year, yet the cases of overdoses causing acute liver failure number in the hundreds, and a large percentage of those are suicide attempts. Over all, it’s a remarkably safe drug.

2. If it’s about NSAIDs, it doesn’t apply to acetaminophen. Most of the pain relievers that we’re familiar with, like ibuprofen, naproxen, and some that aren’t so familiar, like diclofenac (Cataflam, Voltaren), are nonsteroidal anti-inflammatory drugs (NSAIDs). As the name implies, they quell pain by quieting inflammation. Acetaminophen, however, is not an NSAID. It is not anti-inflammatory and relieves pain in other ways.

3. All the NSAIDs may increase heart attack risk. NSAIDs revolutionized the treatment of pain but have the drawback of being hard on the stomach; in extreme cases, they cause gastrointestinal bleeding, a serious — sometimes deadly — side effect.

The COX-2 inhibitors — celecoxib (Celebrex), rofecoxib (Vioxx), valdecoxib (Bextra) — were supposed to be the better NSAIDs: a new generation of medications that would relieve pain just as well as, if not better than, the old NSAIDs, but spare the gut.

Of course, it hasn’t worked out that way — to put it mildly. Vioxx was yanked from the market in 2004 after it was linked to an increased risk for heart attacks. Lawsuits, court cases (the verdicts have gone both ways), and a bitter controversy about incomplete reporting of research results ensued. Bextra came off the market a few months after Vioxx because of possible cardiovascular effects and a link to a potentially fatal skin disease.  The COX-2 inhibitor Celebrex remains on the market. Celebrex and some of the other COX-2 drugs (such as meloxicam, sold as Mobic) may be safer than Vioxx and Bextra because they inhibit not just the COX-2 enzyme but also the COX-1 to some degree, which is closer to the way the traditional NSAIDs work.

Soon all the NSAIDs fell under a cloud of suspicion — and it’s still there. Finnish researchers reported in 2006 that use of all NSAIDs increased the user’s risk of having a heart attack. An earlier Danish study came to a similar conclusion. And Harvard researchers, analyzing data from the Nurses’ Health Study, have found that heavy users (at least 22 days per month) of the traditional NSAIDs are twice as likely to have a heart attack or stroke as those who took fewer of the pills. But in the nurses’ study, it was only smokers who had increased heart disease risk from NSAIDs.

When a pair of Australian researchers combined the results from 23 studies, diclofenac, indomethacin (Indocin), and Vioxx stood out as the NSAIDs most likely to have cardiovascular side effects. Ibuprofen and piroxicam (Feldene) increased risk only slightly, and naproxen, not at all.

4. Naproxen may be the safest one for the heart. Other studies besides the Australians’ have concluded that naproxen doesn’t increase heart attack risk. Although the Finnish study didn’t give it a clean bill of health, of all the NSAIDs, naproxen increased heart attack risk the least. Whether naproxen, like aspirin, might actually protect people from heart attacks remains unclear. The Australians found no evidence of a protective effect, but a Harvard study in 2006 did, as have some others.

5. Low doses of Celebrex seem to be safe. After the bad news about Vioxx and Bextra, the future of all the COX-2 drugs was in doubt. But Celebrex has stayed on the market, and at doses of 200 mg per day or less, doesn’t seem to make a heart attack any more likely. (We’re hedging our bets a little because study results haven’t been uniformly positive.)

6. You can take something to help with the stomach woes. If NSAIDs bother your stomach or you’re at high risk for gastrointestinal complications, taking a proton pump inhibitor like omeprazole (Prilosec) or lansoprazole (Prevacid) can help. Taking one of these offsets the side effect.

7. Take your daily aspirin before ibuprofen or naproxen. If you’re worried about possible heart-related complications from taking NSAIDs, consider taking a low dose of aspirin. Small daily doses of aspirin (the standard amount is 81 mg) make platelets less “sticky,” which reduces the chances of the formation of a blood clot in an artery that supplies the heart or brain. Aspirin has this anti-adhesive effect because it gloms on to an enzyme called cyclooxygenase, which indirectly controls the levels of the substance (thromboxane A2) that gives platelets their stick. Ibuprofen and naproxen also seek out cyclooxygenase. If they get there first, there’s no room for aspirin.

The FDA recommends that when you take aspirin for cardiovascular protection, you should wait at least 30 minutes before taking ibuprofen. Alternatively, you can take an aspirin eight hours after taking ibuprofen. The FDA recommendation doesn’t include naproxen, but studies have shown that naproxen can also prevent aspirin from attaching to the the cyclooxygenase enzyme.

8. Beware of blood pressure increases. The NSAIDs, including the COX-2 drugs, tend to boost blood pressure. The effect is strongest and happens more consistently in people who have high blood pressure already and are taking medication to control it, but there’s evidence that people with normal blood pressure are also affected. Acetaminophen, in high doses and among women, has also been shown to cause small hikes in blood pressure. Low-dose aspirin doesn’t increase blood pressure and may, in fact, work to lower it if you take it at night.

9. Don’t go cold turkey. If you take an NSAID regularly, don’t stop suddenly. Sudden withdrawal makes blood clots more likely to form. Talk to your doctor about lowering your dose gradually and possibly taking a low-dose aspirin if you aren’t taking one already.

10. Beware of kidney woes. NSAIDs, including the COX-2 drugs, can be hard on the kidneys and, in extreme cases, cause kidney failure. Aspirin, ibuprofen, and perhaps sulindac (Clinoril) are less risky in this regard.

11. The dose matters. Many of the risks associated with pain relievers emerge only after long-term or heavy use. You shouldn’t be scared about taking the occasional Advil or Aleve for a headache or aches and pains. The risk is negligible.

12. Your genes matter. There is a lot of individual variation in how people react to pain relievers. For some, Celebrex may be the only pill that works. For others, acetaminophen does the trick. It may take some trial and error to find the pill that works best for you.

For more information on pain, order our Special Health Report, Low-Back Pain: Healing your aching back, at www.health.harvard.edu/LBP.

 
FOR FURTHER READING

To learn more about managing back pain using medications, home remedies, and lifestyle treatments such as exercise, read our Special Health Report, Low Back Pain: Healing your aching back.

[READ MORE or BUY]
    [Back to top]

2\ Notable from Harvard Medical School
** Low-Back Pain: Healing your aching back

This report covers the most common causes of low back pain, diagnostic tests and procedures, and the most effective techniques to treat particular back problems. Armed with the information provided in this report, you’ll be better able to work with your physician to solve the mystery of your ailing back and get on the mend.
 
[CLICK TO READ MORE or BUY]
** Arthritis: Keeping your joints healthy

Joint pain? Swelling? Arthritis is no longer an inevitable consequence of aging, nor is the joint pain and swelling that accompanies it! You don’t have to live in pain. With a host of new therapies available, find out which one may be right for you.
 
[CLICK TO READ MORE or BUY]
[Back to top]

3\ Glucosamine and chondroitin sulfate for osteoarthritis of the knee

Q: For several months, I’ve been taking a glucosamine-chondroitin supplement, but I still get painful flare-ups. Do these supplements really work? What else can I do to ease the pain?

A: Until recently, glucosamine supplements (with or without chondroitin sulfate) held great promise as a treatment for the more than 20 million Americans affected by osteoarthritis, a chronic disorder characterized by the breakdown of cartilage in the joints and painful bone-on-bone friction. Both glucosamine and chondroitin sulfate are biochemicals that occur naturally in the body and are involved in the growth, repair, and maintenance of cartilage. Early research suggested that these compounds might slow cartilage deterioration and relieve osteoarthritis symptoms, including pain, stiffness, and reduced function. Since habitual use of traditional pain relievers — acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) — carries the risk of serious side effects, the public embraced these supplements as a safe long-term option.

Osteoarthritis of the knee



Osteoarthritis is characterized by the breakdown of cartilage, a protective tissue that covers the ends of bones. In the knee, the cartilage covering the condyles (the knobs at the lower end of the thigh bone) degrades, which can result in the femur and tibia rubbing against each other.

Some studies of glucosamine and chondroitin sulfate have shown benefits, but these were small and, in some cases, sponsored by groups with a financial interest in the supplements. To settle the question, the National Institutes of Health sponsored the Glucosamine/chondroitin Arthritis Intervention Trial (GAIT), a large, randomized controlled trial of glucosamine and chondroitin sulfate supplements in people with osteoarthritis of the knee. The average age of participants was 59, and 64% were women. All had mild to moderate or severe knee pain and x-ray evidence of osteoarthritis. For six months, participants were assigned to groups that variously took glucosamine, chondroitin sulfate, glucosamine and chondroitin together, celecoxib (Celebrex), or a placebo. Symptoms were monitored every four to eight weeks.

The GAIT investigators found that, overall, the supplements didn’t reduce pain any better than a placebo. Broken out by groups, the data suggested that combined glucosamine and chondroitin sulfate helped ease moderate to severe (not mild) pain; but the numbers of patients were too small to be certain. Results were published in the New England Journal of Medicine (Feb. 23, 2006).

The GAIT researchers are now carefully analyzing the x-ray data, in part because earlier x-ray studies suggested that glucosamine and chondroitin sulfate slowed osteoarthritis progression.

Given these findings, it’s hard to be enthusiastic about glucosamine and chondroitin sulfate for osteoarthritis in the knee. We don’t know if the supplements would be more effective taken for a longer time. They’re fairly safe but can be expensive, and they’re not FDA-regulated, so ingredients and amounts may vary.

If you plan to take glucosamine and chondroitin sulfate, keep some points in mind. The supplement hasn’t been tested in elderly or pregnant women. Chondroitin sulfate is chemically similar to blood-thinning drugs such as Coumadin (warfarin), heparin, and aspirin and can cause excessive bleeding. People with diabetes should be aware that in animal studies, glucosamine increases blood sugar levels. (No such effects were found in GAIT participants, but the study wasn’t specifically designed to address that question.)

Whether or not you take glucosamine and chondroitin sulfate, there are several things you can do to reduce osteoarthritis symptoms. Resistance exercise can strengthen the muscles surrounding your painful joints, helping to support them and reduce stress on them. Aerobic conditioning will improve your endurance. Weight control is crucial to reducing both the physical load on joints and the resulting pain. If your pain is due to joint misalignment, check with your doctor to see if you would benefit from a brace or an orthotic in your shoe. Devices like canes, walkers, and raised seats relieve stress on joints. Also consider heat and ice, analgesics (NSAIDs and acetaminophen), and topical pain relievers such as capsaicin cream (made from the active ingredient in hot pepper).

— Celeste Robb-Nicholson, M.D.
Editor in Chief, Harvard Women’s Health Watch

This Question and Answer first appeared in the June 2006 Harvard Women’s Health Watch, available at www.health.harvard.edu/women.

 
FOR FURTHER READING

For more information on what treatments are best for your arthritis pain, order our special health report, Arthritis: Keeping your joints healthy.

[READ MORE or BUY]
    [Back to top]

Harvard Medical School publishes authoritative Special Health Reports on a wide range of topics. Each report delivers practical information on diagnosis, treatment, and prevention of major health concerns in clear, easy-to-understand language. For more information on a specific topic, click the appropriate link below:

Alzheimer’s, Arthritis, Bladder, Cholesterol, Depression, Diabetes, Digestion, Energy, Exercise, Eye Disease, Headache, Heart Disease, High Blood Pressure, Memory, Menopause, Prostate, Sexuality, Sleep, Stroke, Vitamins

 
[Back to top]

Harvard Medical School offers special reports on over 50 health topics. Visit our Web site at http://www.health.harvard.edu to find reports of interest to you and your family.

Copyright 2007 by the President and Fellows of Harvard College.
To view our archive of past HEALTHbeat e-newsletters click here.
Harvard Health Publications
Harvard Medical School

10 Shattuck Street, Suite 612
Boston, MA 02115 USA
Visit our Web site at: www.health.harvard.edu
Email us at: HEALTHbeat@hms.harvard.edu
* Please note, we do not provide responses to personal medical concerns, nor can we supply related medical information, other than what is available in our print products or Web site. For specific, personalized medical advice we encourage you to contact your physician.
HEALTHbeat is distributed to individuals who have subscribed via the Harvard Health Publications Web site (www.health.harvard.edu/healthbeat). You are currently subscribed to HEALTHbeat as %%$email%%.
PHONE ORDERS
To order a subscription or Special Health Report by phone, please call our toll free number 1-877-649-9457.
TELL A FRIEND
Share the gift of good health with your friends and family. Follow this link and fill out the form. We’ll send your friends an email invitation to sign up for HEALTHbeat, and a FREE gift if they sign up.
TO JOIN OUR E-MAIL LIST
If you would like to receive HEALTHbeat, our free e-mail newsletter, visit www.health.harvard.edu/healthbeat and fill out our form. It’s that simple.
TO STOP RECEIVING HEALTHbeat
You can remove yourself from our e-mailing list at any time by clicking this link.